Outcomes of High Kidney Donor Profile Index Hepatitis C Nucleic Acid Testing Positive Kidneys are Equivalent to Matched Hepatitis C Nucleic Acid Testing Negative Kidneys
Open Access
- 27 June 2025
- journal article
- kidney transplantation
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (7) , e1827
Abstract
Background.: A recent Organ Procurement and Transplant Network policy change removes hepatitis C virus (HCV) status and race from the Kidney Donor Profile Index (KDPI) calculation, thereby lowering the KDPI of HCV nucleic acid testing positive (NAT+) kidneys and increasing their allocation priority. However, even in the era of direct-acting antivirals, high KDPI HCV NAT+ kidneys exhibited higher discard rates compared with their HCV NAT– counterparts, and outcome data for this “high-risk” group remain limited. This study aims to address this knowledge gap by providing comprehensive outcome data to better inform organ allocation and selection decisions under the new KDPI framework. Methods.: Using national transplant data from 2015 to 2023, we analyzed adult deceased donor kidney transplants stratified by KDPI and HCV NAT status. An exact matching model was used to identify the matched HCV NAT– group. Results.: No significant differences were observed in delayed graft function, rejection, or patient and graft survival between high KDPI HCV NAT+ and matched HCV NAT– recipients. High KDPI HCV NAT+ kidneys were more often allocated regionally or nationally, with 67.6% occurring in 4 regions. Their recipients were more likely to have a high school education and shorter wait times. After the policy change, >90% of prior high KDPI HCV NAT+ kidneys will no longer be classified as high KDPI. Conclusions.: Our findings support the safe utilization of previously high KDPI HCV NAT+ kidneys after a policy change. Although the revised KDPI may assist clinicians in identifying higher-quality organs, its impact on existing sociodemographic disparities and overall organ utilization rate remains uncertain.Keywords
This publication has 31 references indexed in Scilit:
- Updating the kidney donor risk index: Removing donor race and hepatitis C virus statusAmerican Journal of Transplantation, 2025
- Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney TransplantationTransplantation Proceedings, 2024
- OPTN/SRTR 2022 Annual Data Report: KidneyAmerican Journal of Transplantation, 2024
- The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medicationsAmerican Journal of Transplantation, 2023
- Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy EraJAMA, 2022
- One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) TrialKidney International Reports, 2021
- A review of kidney transplantation from HCV-viremic donors into HCV-negative recipientsKidney International, 2021
- Limited health literacy is associated with reduced access to kidney transplantationKidney International, 2019
- The Kidney Allocation SystemSurgical Clinics of North America, 2013
- Educational Level as a Determinant of Access to and Outcomes After Kidney Transplantation in the United StatesAmerican Journal of Kidney Diseases, 2008